EUVIMEDEUVIMED entdecken
Open Access

Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes

Alessandra Vultaggio, Matteo Accinno, Emanuele Vivarelli, Maria Elena Milanese, Michael Diomaiuti, Gennaro Illiano, Pietro Orlando iD, Annarita Palomba, Carlo Ammatuna, Lorenzo Cosmi, Oliviero Rossi, Enrico Maggi und 2 weitere

Clinical & Experimental Allergy · 2026-08 · 56 (8) · 920-922

DOI: 10.1111/cea.70309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 17.04.2026. Verfasst von Alessandra Vultaggio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunoallergology Unit, Careggi University Hospital, Florence, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Ministry of University and Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dupilumab reduces tissue eosinophils in nasal polyps beyond improving clinical and endoscopic outcomes. Dupilumab treatment is associated with a reduction of tissue inflammatory eosinophils that correlates with higher clinical and endoscopic improvement.

Autor:innen und Institutionen

  • Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Otolaryngology Clinic, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Department of Pathology, Careggi University Hospital, Florence, Italy.

ORCID-Profile: Pietro Orlando, Andrea Matucci

Förderung

  • National Ministry of University and Research

Zitieren

APA

Vultaggio, A., Accinno, M., Vivarelli, E., Milanese, M. E., Diomaiuti, M., Illiano, G., Orlando, P., Palomba, A., Ammatuna, C., Cosmi, L., Rossi, O., Maggi, E., Maggiore, G., & Matucci, A. (2026). Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes. Clinical & Experimental Allergy, 56(8), 920-922. https://doi.org/10.1111/cea.70309

Vancouver

Vultaggio A, Accinno M, Vivarelli E, Milanese ME, Diomaiuti M, Illiano G, et al. Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes. Clinical & Experimental Allergy. 2026;56(8):920-922. doi:10.1111/cea.70309

BibTeX
@article{Vultaggio2026,
  author = {Vultaggio, Alessandra and Accinno, Matteo and Vivarelli, Emanuele and Milanese, Maria Elena and Diomaiuti, Michael and Illiano, Gennaro and Orlando, Pietro and Palomba, Annarita and Ammatuna, Carlo and Cosmi, Lorenzo and Rossi, Oliviero and Maggi, Enrico and Maggiore, Giandomenico and Matucci, Andrea},
  title = {Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {8},
  pages = {920--922},
  doi = {10.1111/cea.70309}
}
Kostenlos starten →